A comparison of polymer and polymer-hydroxyapatite composite tissue engineered scaffolds for use in bone regeneration. An in vitro and in vivo study

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 8, 2014, Pages 2613-2624

  Tayton, E ^a   Purcell, M ^b   Aarvold, A ^a   Smith, J O ^a   Briscoe, A ^a   Kanczler, J M ^a   Shakesheff, K M ^b   Howdle, S M ^b   Dunlop, D G ^a   Oreffo, R O C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

bone regeneration; polymer; progenitor cell; scaffold; skeletal stem cell

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; COPOLYMERS; HYDROXYAPATITE; SCAFFOLDS; SCAFFOLDS (BIOLOGY); STEM CELLS;

BONE GRAFT SUBSTITUTES; BONE REGENERATION; CELLULAR COMPATIBILITY; CLINICAL TRANSLATION; IMPACTION BONE GRAFTING; OSTEOBLASTIC ACTIVITY; OSTEOGENIC CAPACITY; PROGENITOR CELL;

POLYMERS;

COLLAGEN TYPE 1; HYDROXYAPATITE; POLYGLACTIN; POLYMER; ALKALINE PHOSPHATASE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

AGED; ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASSAY; BONE DEVELOPMENT; BONE REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; SHEAR STRENGTH; STEM CELL; TISSUE ENGINEERING; ANALYSIS OF VARIANCE; ANIMAL; BONE; CELL DIFFERENTIATION; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; IMAGE PROCESSING; MATERIALS TESTING; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; NUDE MOUSE; PROCEDURES; RADIOGRAPHY; TISSUE SCAFFOLD;

AGED; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; ANIMALS; BONE AND BONES; BONE REGENERATION; CELL DIFFERENTIATION; CELL SURVIVAL; COLLAGEN TYPE I; DURAPATITE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LACTIC ACID; MALE; MATERIALS TESTING; MICE, NUDE; POLYGLYCOLIC ACID; POLYMERS; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84903312403     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34926     Document Type: Article

References (37)

1. Hing KA, Revell PA, Smith N, Buckland T,. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials 2006; 27: 5014-5026.
2. Beswick A, Blom AW,. Bone graft substitutes in hip revision surgery: A comprehensive overview. Injury 2011; 42 Suppl 2: S40-S46.
3. Woodard JR, et al. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 2007; 28: 45-54.
4. Lin L, Chow KL, Leng Y,. Study of hydroxyapatite osteoinductivity with an osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A 2009; 89: 326-335.
5. Giannoudis PV, Dinopoulos H, Tsiridis E,. Bone substitutes: An update. Injury 2005; 36 Suppl 3: 20-27.
6. Oakley J, Kuiper JH,. Factors affecting the cohesion of impaction bone graft. J Bone Joint Surg Br 2006; 88: 828-831.
7. McNamara I, Deshpande S, Porteous M,. Impaction grafting of the acetabulum with a mixture of frozen, ground irradiated bone graft and porous synthetic bone substitute (Apapore 60). J Bone Joint Surg Br 2010; 92: 617-623.
8. Blom AW, Wylde V, Livesey C, Whitehouse MR, Eastaugh-Waring S, Bannister GC, Learmonth ID,. Impaction bone grafting of the acetabulum at hip revision using a mix of bone chips and a biphasic porous ceramic bone graft substitute. Acta Orthop 2009; 80: 150-154.
9. Tomford WW, Starkweather RJ, Goldman MH,. A study of the clinical incidence of infection in the use of banked allograft bone. J Bone Joint Surg Am 1981; 63: 244-248.
10. Tomford WW, Schachar NS, Fuller TC, Henry WB, Mankin HJ,. Immunogenicity of frozen osteoarticular allografts. Transplant Proc 1981; 13: 888-890.
11. Galea G, Kopman D, Graham BJ,. Supply and demand of bone allograft for revision hip surgery in Scotland. J Bone Joint Surg Br 1998; 80: 595-599.
12. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC,. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007; 1: 245-260.
13. Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO,. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010; 31: 1242-1250.
14. Tayton E, Fahmy S, Purcell M, Aarvold A, Smith JO, Kalra S, Briscoe A, Lanham S, Howdle S, Shakesheff K, Dunlop DG, Oreffo RO. An analysis of polymer type and chain length for use as a biological composite graft extender in impaction bone grafting: A mechanical and biocompatibility study. J Biomed Mater Res A 2012; 100: 3211-3219.
15. Tayton E, Purcell M, Aarvold A, Smith JO, Kalra S, Briscoe A, Shakesheff K, Howdle SM, Dunlop DG, Oreffo RO. Supercritical CO2 fluid-foaming of polymers to increase porosity: A method to improve the mechanical and biocompatibility characteristics for use as a potential alternative to allografts in impaction bone grafting? Acta Biomater 2012; 8: 1918-1927.
16. Brewster NT, Gillespie WJ, Howie CR, Madabhushi SP, Usmani AS, Fairbairn DR,. Mechanical considerations in impaction bone grafting. J.Bone Joint Surg Br 1999; 81: 118-124
17. Kanczler JM, Barry J, Ginty P, Howdle SM, Shakesheff KM, Oreffo RO,. Supercritical carbon dioxide generated vascular endothelial growth factor encapsulated poly(DL-lactic acid) scaffolds induce angiogenesis in vitro. Biochem Biophys Res Commun 2007; 352: 135-141.
18. Bolland BJ, Partridge K, Tilley S, New AM, Dunlop DG, Oreffo RO,. Biological and mechanical enhancement of impacted allograft seeded with human bone marrow stromal cells: Potential clinical role in impaction bone grafting. Regen Med 2006; 1: 457-467.
19. Bolland BJ, Kanczler JM, Dunlop DG, Oreffo RO,. Development of in vivo muCT evaluation of neovascularisation in tissue engineered bone constructs. Bone 2008; 43: 195-202.
20. Miao D, Scutt A,. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 2002; 50: 333-340.
21. Jones AMH, Foong TS, New AM, Bolland BJ, Pound JC, Dunlop DG, Oreffo RO,. The effect of skeletal stem cells, hydroxyapatite coated stem cells and collagen coated allograft on the biomechanical properties of impacted bone graft. Eur Cell Mater 2009; 18 Suppl. 2: 26
22. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K,. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996; 19: 1518-1520.
23. Dunlop DG, Brewster NT, Madabhushi SP, Usmani AS, Pankaj P, Howie CR,. Techniques to improve the shear strength of impacted bone graft: The effect of particle size and washing of the graft. J Bone Joint Surg Am 2003; 85-A: 639-646.
24. Blom AW, Grimm B, Miles AW, Cunningham JL, Learmonth ID,. Subsidence in impaction grafting: The effect of adding a ceramic bone graft extender to bone. Proc Inst Mech Eng H 2002; 216: 265-270.
25. Brennan SA, Brabazon D, O'Byrne JM,. Effect of vibration on the shear strength of impacted bone graft in revision hip surgery. J Bone Joint Surg Br 2011; 93: 755-759.
26. Barbieri D, Renard AJ, de Bruijn JD, Yuan H,. Heterotopic bone formation by nano-apatite containing poly(D,L-lactide) composites. Eur Cell Mater 2010; 19: 252-261.
27. Chen Y, Mac AF, Wang M, Lee J, Wong MS,. PLLA scaffolds with biomimetic apatite coating and biomimetic apatite/collagen composite coating to enhance osteoblast-like cells attachment and activity. Surf Coat Technol 2006; 201: 575-580.
28. Garcia AJ, Reyes CD,. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res 2005; 84: 407-413.
29. Uchida M, Oyane A, Kim HM, Kokubo T, Ito A,. Biomimetic coating of laminin-apatite composite on titanium metal and its excellent cell-adhesive properties. Adv Mater 2004; 16: 1071-1074.
30. Liu Y, Yin Y, Wang L, Zhang W, Chen X, Yang X, Xu J, Ma G. Surface hydrophobicity of microparticles modulates adjuvanticity. J Mater Chem B 2013; 1: 3888-3896.
31. Ho ST, Hutmacher DW,. A comparison of micro CT with other techniques used in the characterization of scaffolds. Biomaterials 2006; 27: 1362-1376.
32. Ripamonti U,. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 1996; 17: 31-35.
33. Athanasiou KA, Niederauer GG, Agrawal CM,. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
34. Taylor MS, Daniels AU, Andriano KP, Heller J,. Six bioabsorbable polymers: In vitro acute toxicity of accumulated degradation products. J Appl Biomater 1994; 5: 151-157.
35. Murphy WL, Dennis RG, Kileny JL, Mooney DJ,. Salt fusion: An approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng 2002; 8: 43-52.
36. Nam YS, Yoon JJ, Park TG,. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. J Biomed Mater Res 2000; 53: 1-7.
37. Tai H, Popov VK, Shakesheff KM, Howdle SM,. Putting the fizz into chemistry: Applications of supercritical carbon dioxide in tissue engineering, drug delivery and synthesis of novel block copolymers. Biochem Soc Trans 2007; 35: 516-521.